Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: J Trauma Acute Care Surg. 2018 Feb;84(2):350–357. doi: 10.1097/TA.0000000000001730

Table 4.

Univariate associations between resuscitation parameters, acute kidney injury, and primary fascial closure among patients who underwent emergent laparotomy and temporary abdominal closure (TAC).

Time
period
Resuscitation
parameters
Acute kidney injurya Primary fascial closure
OR 95% CI p OR 95% CI p
POD 0b 3% HTS administration 1.01 0.49–2.08 0.986 3.26 0.94–11.28 0.062

0–48h IVFc administered (L) 1.00 0.94–1.06 0.952 0.90 0.83–0.97 0.003
NPWT output (L) 1.17 0.96–1.42 0.119 0.72 0.58–0.90 0.003

48h Sodium (mEq/L) 1.00 0.94–1.06 0.865 1.03 0.95–1.11 0.454
Chloride (mEq/L) 0.98 0.93–1.03 0.485 1.11 1.03–1.19 0.006
Osmolarity (mosm/kg) 1.01 0.99–1.04 0.413 1.01 0.98–1.04 0.526

48–96h IVFc administered (L) 1.02 0.95–1.11 0.586 0.88 0.80–0.97 0.007
NPWT output (L) 1.23 1.01–1.51 0.040 0.62 0.49–0.79 <0.001

96h Sodium (mEq/L) 0.98 0.94–1.02 0.355 0.98 0.93–1.04 0.555
Chloride (mEq/L) 0.99 0.94–1.04 0.711 1.00 0.94–1.07 0.973
Osmolarity (mosm/kg) 0.99 0.98–1.01 0.291 1.00 0.99–1.01 0.495

96h–7d IVFc administered (L) 1.05 0.98–1.13 0.177 0.93 0.85–1.02 0.101
NPWT output (L) 1.24 1.02–1.50 0.034 0.70 0.57–0.86 0.001

7d Sodium (mEq/L) 1.02 0.96–1.07 0.555 0.93 0.87–1.00 0.035
Chloride (mEq/L) 1.03 0.98–1.09 0.242 0.95 0.89–1.02 0.133
Osmolarity (mosm/kg) 1.01 0.99–1.03 0.176 0.97 0.95–1.00 0.016

OR: odds ratio, CI: confidence interval, HTS: hypertonic saline, IVF: intravenous fluid, NPWT: negative pressure wound therapy. Sodium, chloride, and osmolarity values were measured in serum.

a

Stage 2 or 3 acute kidney injury within seven days of exploratory laparotomy and temporary abdominal closure per consensus Kidney Disease: Improving Global Outcomes (KDIGO) definitions.

b

HTS was initiated on postoperative day zero following TAC and continued until fascial closure or postoperative day 3, whichever occurred first.

c

Including maintenance crystalloid fluids, bolus crystalloid fluids, piggyback fluids for medication administration, and parenteral nutrition.